Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surveillance MRI for Brain Metastases in Stage III Non-Squamous NSCLC
NCT05692635Phase 2Recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Aug 2023
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in non-small cell lung cancer (NSCLC), sponsored by Wake Forest University Health Sciences. Primary endpoint: Change in Central Nervous System Symptoms at 26 months. Started Aug 2023; status: recruiting.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05692635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05692635.